Status:
COMPLETED
A Trial Comparing the Effect of Pravastatin and Rosuvastatin on Atherosclerosis Progression Measured by Carotid Intima Media Thickness in Patients With Coronary Artery Disease After Biolimus Eluting Stent (Nobori®) Implantation: CPR IMT
Lead Sponsor:
Yonsei University
Conditions:
Coronary Artery Occlusive Disease
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Current consensus papers recommend statin medication to reduce Low density lipoprotein (LDL) cholesterol level less than 100mg/dL (optional 70mg/dL) in patients with coronary artery disease. However, ...
Eligibility Criteria
Inclusion
- Patients ≥ 20 years old
- Patients with coronary artery disease who are candidate for coronary revascularization with DES implantation.
- Significant coronary de novo lesion (stenosis \> 70% by quantitative angiographic analysis)
- Patients eligible for statin treatment (initial LDL cholesterol \>70mg/dL or patients taking lipid-lowering agent)
Exclusion
- Severe hepatic dysfunction (3 times normal reference values)
- Pregnant women or women with potential childbearing
- Life expectancy \< 1 year
Key Trial Info
Start Date :
June 12 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2017
Estimated Enrollment :
671 Patients enrolled
Trial Details
Trial ID
NCT01872845
Start Date
June 12 2013
End Date
May 25 2017
Last Update
January 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital
Seoul, South Korea, 120-752